Jubilant Pharmova Ltd. (JUBLPHARMA): Jubilant Pharmova Share Price Falls 5.96% Today as Mid Cap Stock Turns Top Decliner
- August 12, 2026
- Posted by: Harsh Piplani
- Category: News
Jubilant Pharmova fell to Rs 905.3, down 5.96% today. The mid cap healthcare stock, with market capitalisation of Rs 15,318.07 crore, entered the top decliner list.
Jubilant Pharmova Share Price is in focus today after the stock fell to Rs 905.3, down 5.96% from its previous close of Rs 962.7. With a market capitalisation of Rs 15,318.07 crore, Jubilant Pharmova Ltd. has moved into the spotlight in Stock Market Today as a notable mid cap loser within the healthcare space. The supplied data confirms a sharp same-day share price decline and shows that the move was large enough to trigger a Price Fall Threshold event for its Mid Cap classification.
For investors tracking Jubilant Pharmova Share Price Today, the early session data shows a weak start and continued pressure through the intraday range. The stock opened at Rs 968, which also marked the day’s high, and then slipped to a low of Rs 900.1 before trading at Rs 905.3 at the time captured in this update. That pattern matters because it indicates sellers remained in control after the open rather than the stock recovering from the initial weakness.
Jubilant Pharmova Stock News is trending because the decline is meaningful in percentage terms, material in rupee terms at Rs 57.4 per share, and relevant for market watchers looking at Top Losers Today in the Indian Stock Market. The supplied data confirms what happened on price and volume, but it does not establish a company-specific catalyst behind the fall. For readers of Univest, the key issues now are the day’s price action, how the stock sits within its sector context, and what peer and market-cap data imply about relative positioning.
Jubilant Pharmova Ltd. (JUBLPHARMA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 905.3 |
| Previous Close | Rs 962.7 |
| Today's Change | Rs -57.4 (-5.96%) |
| Day Open | Rs 968 |
| Day High | Rs 968 |
| Day Low | Rs 900.1 |
| Current Volume (BSE) | 16,527 |
| BSE Traded Volume | 16,527 |
| NSE Traded Volume | 2,73,834 |
| Combined NSE + BSE Volume | 2,90,361 |
| Turnover | Rs 1.5 crore |
| Market Capitalisation | Rs 15,318.07 crore |
| Market Cap Category | Mid Cap |
Jubilant Pharmova Ltd. (JUBLPHARMA) traded at Rs 905.3. versus the previous close of Rs 962.7, a fall of 5.96%. The stock opened at Rs 968, reached Rs 968, touched Rs 900.1. Reported volume was 16,527.
Jubilant Pharmova Ltd. (JUBLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,318.07 crore |
Jubilant Pharmova Share Price is drawing attention primarily because of today’s move, but the company’s size also matters for context. At a market capitalisation of Rs 15,318.07 crore, Jubilant Pharmova is well above the median and average market-cap figures shown in the supplied healthcare benchmark set. That does not, by itself, say anything about quality or direction, but it does confirm that this is not a thinly tracked micro name. A price fall in a stock of this size tends to attract broader attention in Share Market Today and among investors screening for market movers.
In the supplied dataset, the strongest fundamental anchor available for Jubilant Pharmova Fundamental Analysis is that market-cap context. The healthcare benchmark covers 196 companies in the same sector, with a median market capitalisation of Rs 142.81 crore and an average of Rs 461.64 crore. Against that backdrop, Jubilant Pharmova’s Rs 15,318.07 crore valuation stands far above the benchmark’s average and even above the highest benchmark company listed in the sector snapshot, which is Rs 2,949.87 crore. This makes Jubilant Pharmova a much larger listed entity than the benchmark examples inserted for comparison.
That scale matters when investors interpret Jubilant Pharmova Stock Analysis. A one-day decline of 5.96% in a company with market capitalisation above Rs 15,000 crore represents a meaningful move in market value terms, not just in percentage terms. It can therefore influence short-term sentiment around the stock even without a verified company-specific trigger in the supplied data.
For Univest, the fundamental takeaway is disciplined rather than dramatic. The verified data confirms company size, sector placement and the material nature of the day’s decline. It does not, on its own, justify a directional conclusion. That is why the next layer of analysis is less about rating the stock and more about locating Jubilant Pharmova Share Price within sector benchmarks and peer positioning.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 25.58x |
| Benchmark Average P/E | 81.68x |
| Benchmark P/E Range | 3.31x to 3,374.81x |
| Benchmark Median P/B | 1.9x |
| Benchmark Median ROE | 11.07% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 15,318.07 crore |
| Benchmark Median Market Cap | Rs 142.81 crore |
Jubilant Pharmova Ltd. (JUBLPHARMA) is classified under sector: Healthcare.
Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Jubilant Pharmova Share Price is moving within the healthcare sector, and the supplied benchmark data shows a wide spread in valuations, profitability and market capitalisation across 196 same-sector companies. That matters because today’s decline should be read against a broad and diverse listed universe rather than a narrow single-stock lens.
The healthcare sector snapshot covers 196 companies in the same sector. Within that sample, 156 companies have P/E data, where the median stands at 25.58 and the average at 81.68, with a range from 3.31 to 3374.81. For price-to-book, 195 companies are counted, with a median of 1.9, an average of 2.6, a minimum of -16.74 and a maximum of 16.32. Profitability dispersion is also broad. ROE across 195 companies has a median of 11.07 and an average of 15.45, while ROCE across 195 companies has a median of 13.35 and an average of 17.8.
For Jubilant Pharmova Share Price News, the most concrete sector comparison available is market capitalisation. The sector’s median market cap is Rs 142.81 crore, the average is Rs 461.64 crore, the minimum is Rs 3.88 crore and the maximum in the supplied benchmark list is Rs 2,949.87 crore. Jubilant Pharmova, at Rs 15,318.07 crore, sits far above those benchmark levels. That indicates investors are dealing with a company that is larger than many healthcare names included in the same-sector basket.
Univest reads this as important context rather than a conclusion. The sector data shows that healthcare names can trade across a very wide valuation and profitability range. It also shows that size leadership does not insulate a stock from a sharp same-day decline. In other words, today’s Jubilant Pharmova Share Price Fall appears company-specific in market behaviour, even though the supplied data does not confirm the underlying cause.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,949.87 | 31.07 | 0.45 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,775.9 | 71.31 | 11.28 | 18.65 | 22.17 |
| Hikal Ltd. | HIKAL | 2,761.32 | 0 | 2.26 | 15.22 | 16.15 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,594.65 | 179.52 | 3.32 | 13.9 | 12.97 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,561.88 | 33.61 | 6.93 | -2.6 | 16.92 |
Jubilant Pharmova Ltd. (JUBLPHARMA) has a market capitalisation of Rs 15,318.07 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Jubilant Pharmova Share Price can also be framed through the supplied peer set, which includes listed healthcare names across pharmaceuticals and healthcare services. The peer group data shows wide differences in valuation and profitability, while Jubilant Pharmova itself stands out on scale because its market capitalisation of Rs 15,318.07 crore is above every peer listed in the supplied snapshot.
Among the named peers, Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,949.87 crore with P/E of 31.07, P/B of 0.45, ROE of -2.89 and ROCE of -0.26. Beta Drugs Ltd. stands at Rs 2,775.9 crore with P/E of 71.31, P/B of 11.28, ROE of 18.65 and ROCE of 22.17. Hikal Ltd. has a market cap of Rs 2,761.32 crore with P/B of 2.26, ROE of 15.22 and ROCE of 16.15. Sai Parenteral’s Ltd. is at Rs 2,594.65 crore with P/E of 179.52, P/B of 3.32, ROE of 13.9 and ROCE of 12.97.
The rest of the peer basket reinforces the dispersion. Dr Agarwals Eye Hospital Ltd. has a market cap of Rs 2,561.88 crore, P/E of 33.61, P/B of 6.93, ROE of -2.6 and ROCE of 16.92. NGL Fine-Chem Ltd. shows P/E of 44.41, P/B of 6.49, ROE of 27.9 and ROCE of 33.91 on a market cap of Rs 2,140.53 crore, while Hester Biosciences Ltd. trades at P/E of 15.51 and P/B of 4.64 with ROE of 16.17 and ROCE of 14.12.
For Univest readers, the peer message is straightforward. Jubilant Pharmova Share Price is being repriced today in a sector where peer valuation and profitability numbers vary sharply. The available peer data helps frame the competitive listed environment, while Jubilant Pharmova’s much larger market cap underlines that this is a larger healthcare stock facing notable one-day pressure.
Why Investors Are Watching Jubilant Pharmova
Jubilant Pharmova Share Price is being watched because the stock has recorded a meaningful one-day decline in a relatively large healthcare company. The move is relevant for traders focused on intraday weakness and for longer-horizon investors who track market-cap leaders, sector rotation and stock-specific price behaviour on platforms such as Univest.
- Price action: The stock fell 5.96%, or Rs 57.4, from Rs 962.7 to Rs 905.3.
- Intraday structure: It opened at Rs 968, which was also the day’s high, then fell to Rs 900.1.
- Volume context: Total volume reached 2,90,361 shares, including 2,73,834 on NSE and 16,527 on BSE.
- Market-cap significance: At Rs 15,318.07 crore, the company is materially larger than the benchmark healthcare examples supplied.
- Sector context: The stock operates in healthcare, a sector where benchmark valuation and profitability ranges are wide.
What investors may monitor next is whether Jubilant Pharmova Share Price stabilises nearer the day low or regains ground from current levels, and whether subsequent sessions show continued Stocks Under Pressure behaviour or a narrower trading range. Univest would also watch how the stock’s movement compares with healthcare peers and whether it remains a prominent top decliner in market updates.
About Jubilant Pharmova
Jubilant Pharmova Ltd. is classified in the Healthcare sector in the supplied market data, which places it inside one of the most diverse groups in the Indian listed universe. Within the same-sector benchmark, many companies are from Pharmaceuticals & Drugs, while the wider basket also includes healthcare services names such as Dr Agarwals Eye Hospital Ltd. That context suggests Jubilant Pharmova is being evaluated by the market alongside a broad healthcare opportunity set rather than against a single narrow business model.
For readers searching Jubilant Pharmova Stock News, the practical takeaway is that the company sits in a sector where business profiles, valuation multiples and profitability metrics can differ widely across listed names. In the supplied benchmark basket, P/E ranges from 3.31 to 3374.81, P/B ranges from -16.74 to 16.32, and profitability measures such as ROE and ROCE also vary materially across companies. That means sector membership alone does not define how a stock trades on any given day.
Jubilant Pharmova Share Price therefore needs to be tracked as both a healthcare stock and a larger-cap listed counter in relative terms. With market capitalisation of Rs 15,318.07 crore, the company is materially larger than the benchmark examples supplied here. On Univest, that makes it a stock worth tracking not only for daily price movement but also for how it behaves against sector breadth and peer dispersion.
Track Jubilant Pharmova Share Price on Univest
Use Jubilant Pharmova Ltd. (JUBLPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Investors who want to follow Jubilant Pharmova Share Price can use Univest to monitor live share price updates, day range, market capitalisation, 52-week levels when available, technical indicators when available, valuation ratios when available and shareholding pattern data when disclosed. Univest also helps readers place Jubilant Pharmova Share Price Today in context through sector benchmarks, peer comparison, Stock News coverage and market insights. For stocks appearing among Top Losers Today or other market movers, that contextual approach can be more useful than looking at isolated price moves alone.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Jubilant Pharmova Share Price falling today?
Ans. Jubilant Pharmova Share Price is down 5.96% today, falling Rs 57.4 from the previous close of Rs 962.7 to Rs 905.3. The supplied data confirms the decline and intraday weakness, but it does not identify a company-specific catalyst.
What is Jubilant Pharmova Share Price Today?
Ans. Jubilant Pharmova Share Price Today is Rs 905.3 in the supplied market snapshot. The stock traded between Rs 900.1 and Rs 968 during the session, after closing at Rs 962.7 in the previous trading session.
How much did Jubilant Pharmova stock decline today?
Ans. Jubilant Pharmova stock declined by Rs 57.4, which translates into a 5.96% share price fall for the day. That makes it a notable loser in today’s trade, especially given the company’s Rs 15,318.07 crore market capitalisation.
What does the intraday range show for Jubilant Pharmova?
Ans. The intraday range shows weakness after the open. The stock opened at Rs 968, which was also the session high, then declined to a low of Rs 900.1 before trading at Rs 905.3 in this update.
What is Jubilant Pharmova’s market capitalisation?
Ans. Jubilant Pharmova’s market capitalisation is Rs 15,318.07 crore in the supplied dataset. That places it in the Mid Cap category and makes it much larger than the median and average market-cap figures in the healthcare benchmark snapshot.
How much volume was traded in Jubilant Pharmova today?
Ans. Total traded volume in Jubilant Pharmova stood at 2,90,361 shares in the supplied snapshot. Of this, 2,73,834 shares were on NSE and 16,527 shares were on BSE, showing that activity was concentrated on the NSE.
What was the turnover in Jubilant Pharmova today?
Ans. The supplied data shows turnover of Rs 1.5 crore for Jubilant Pharmova in this market update. Along with the 5.96% decline and 2,90,361 total traded shares, that confirms active participation during the selloff.
Which sector does Jubilant Pharmova belong to?
Ans. Jubilant Pharmova belongs to the Healthcare sector in the supplied dataset. The same-sector benchmark covers 196 companies, highlighting that the stock is part of a broad listed universe with widely varying valuation and profitability profiles.
How does Jubilant Pharmova compare with the healthcare sector on size?
Ans. Jubilant Pharmova is much larger than the supplied healthcare benchmark averages on market capitalisation. Its Rs 15,318.07 crore market cap is above the sector median of Rs 142.81 crore and the average of Rs 461.64 crore.
Why is Jubilant Pharmova in stock news today?
Ans. Jubilant Pharmova is in stock news today because the share price fell 5.96% in a single session, making it a top decliner candidate. Its large market capitalisation also increases visibility across market screens and investor watchlists.
